MF Researcher Database

研究者一覧

詳細

馬場　勇太Baba Yuta

■所属部署名医科薬理学
■職名助教
Last Updated :2026/05/25

研究者情報

基本情報

プロフィール情報

  • 氏名

    馬場　勇太, Baba Yuta

所属

  • 医科薬理学, 助教

施設

  • 旗の台校舎

学位

  • 博士(医学), 昭和大学, 2018年09月

業績

論文

  • Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy, Tajima K, Hosonuma M, Funayama E, Isobe J, Baba Y, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Maruyama Y, Sasaki A, Amari Y, Yamazaki Y, Nakashima R, Shida M, Sasaki A, Sambe T, Wada S, Tsuji M, Kiuchi Y, Kobayashi S, Kuramasu A, Tsunoda T, Mori M, Koyanagi K, Yoshimura K, Int J Cancer, 2025年09月, 原著, 査読あり
  • Intestinal and esophageal microbiota in esophageal cancer development and treatment., Baba Yuta;Tajima Kohei;Yoshimura Kiyoshi, Gut microbes, 17(1), 2025年05月, 総説, 査読あり, DOI:https://doi.org/10.1080/19490976.2025.2505118
  • Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice., Maruyama Yuki;Hosonuma Masahiro;Toyoda Hitoshi;Funayama Eiji;Sasaki Akiko;Baba Yuta;Tajima Kohei;Nakashima Rie;Sasaki Aya;Shida Midori;Tsurui Toshiaki;Tsuji Mayumi;Tsunoda Takuya;Shimane Toshikazu;Kiuchi Yuji;Yoshimura Kiyoshi;Kuramasu Atsuo, European journal of pharmacology, 999, 2025年05月, 原著, 査読あり
  • Acute Myeloid Leukemia with MYC Amplification on a Ring Chromosome 8., Baba Yuta;Sakai Hirotaka;Maeda Nodoka;Abe Maasa;Kabasawa Nobuyuki;Fukuda Tetsuya, Internal medicine (Tokyo, Japan), 2025年04月, 症例報告, 査読あり
  • Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit., Tsurui Toshiaki;Hosonuma Masahiro;Sasaki Aya;Maruyama Yuuki;Amari Yasunobu;Funayama Eiji;Tajima Kohei;Toyoda Hitoshi;Isobe Junya;Yamazaki Yoshitaka;Baba Yuta;Shida Midori;Udaka Yuko;Mura Emiko;Suzuki Risako;Iriguchi Nana;Ishiguro Tomoyuki;Hirasawa Yuya;Ohkuma Ryotaro;Shimokawa Masahiro;Ariizumi Hirotsugu;Kubota Yutaro;Horiike Atsushi;Wada Satoshi;Kuramasu Atsuo;Tsuji Mayumi;Kiuchi Yuji;Tsunoda Takuya;Yoshimura Kiyoshi, Discover oncology, 16(1), 2025年03月, 原著, 査読あり
  • Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice., Funayama Eiji;Hosonuma Masahiro;Tajima Kohei;Isobe Junya;Baba Yuta;Murayama Masakazu;Narikawa Yoichiro;Toyoda Hitoshi;Tsurui Toshiaki;Maruyama Yuki;Sasaki Aya;Amari Yasunobu;Yamazaki Yoshitaka;Nakashima Rie;Uchiyama Jun;Nakano Ryota;Shida Midori;Sasaki Akiko;Udaka Yuko;Oguchi Tatsunori;Sambe Takehiko;Kobayashi Shinichi;Tsuji Mayumi;Kiuchi Yuji;Kim Yun-Gi;Wada Satoshi;Tsunoda Takuya;Akiyama Masahiro;Nobe Koji;Kuramasu Atsuo;Yoshimura Kiyoshi, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 182, 2024年12月, 原著, 査読あり
  • MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells., Toyoda Hitoshi;Kuramasu Atsuo;Hosonuma Masahiro;Murayama Masakazu;Narikawa Yoichiro;Isobe Junya;Baba Yuta;Tajima Kohei;Funayama Eiji;Shida Midori;Maruyama Yuki;Sasaki Aya;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Kobayashi Sei;Horiike Atsushi;Hida Noriko;Sambe Takehiko;Nobe Koji;Wada Satoshi;Kobayashi Hitome;Tsuji Mayumi;Kobayashi Shinichi;Tsunoda Takuya;Kudo Yoshifumi;Kiuchi Yuji;Yoshimura Kiyoshi, Scientific reports, 14(1), 2024年10月, 原著, 査読あり
  • Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody., Murayama Masakazu;Hosonuma Masahiro;Kuramasu Atsuo;Kobayashi Sei;Sasaki Akiko;Baba Yuta;Narikawa Yoichiro;Toyoda Hitoshi;Isobe Junya;Funayama Eiji;Tajima Kohei;Sasaki Aya;Maruyama Yuki;Yamazaki Yoshitaka;Shida Midori;Hamada Kazuyuki;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Horiike Atsushi;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kobayashi Shinichi;Shimane Toshikazu;Tsunoda Takuya;Kobayashi Hitome;Kiuchi Yuji;Yoshimura Kiyoshi, Scientific reports, 14(1), 2024年05月, 原著, 査読あり
  • Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit., Hosonuma Masahiro;Hirasawa Yuya;Kuramasu Atsuo;Murayama Masakazu;Narikawa Yoichiro;Toyoda Hitoshi;Baba Yuta;Isobe Junya;Funayama Eiji;Tajima Kohei;Shida Midori;Hamada Kazuyuki;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Horiike Atsushi;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kiuchi Yuji;Kobayashi Shinichi;Tsunoda Takuya;Yoshimura Kiyoshi, Cancer science, 2024年01月, 原著, 査読あり
  • Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer., Otsuka Koji;Isobe Junya;Asai Yoshiyuki;Nakano Tomohisa;Hattori Kouya;Ariyoshi Tomotake;Yamashita Takeshi;Motegi Kentaro;Saito Akira;Kohmoto Masahiro;Hosonuma Masahiro;Kuramasu Atsuo;Baba Yuta;Murayama Masakazu;Narikawa Yoichiro;Toyoda Hitoshi;Funayama Eiji;Tajima Kohei;Shida Midori;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kiuchi Yuji;Kobayashi Shinichi;Horiike Atsushi;Goto Satoru;Murakami Masahiko;Kim Yun-Gi;Tsunoda Takuya;Yoshimura Kiyoshi, Cancer immunology, immunotherapy : CII, 73(2), 2024年01月, 原著, 査読あり
  • Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience., Baba Yuta;Hida Noriko;Sambe Takehiko;Abe Maasa;Kabasawa Nobuyuki;Sakai Hirotaka;Yoshimura Kiyoshi;Fukuda Tetsuya, Anticancer research, 44(5), 2024年, 原著, 査読あり
  • Chronic neutrophilic leukemia preceded by myelodysplastic syndromes., Baba Yuta;Nakamaki Tsuyoshi;Sakai Hirotaka;Fukuchi Kunihiko;Kabasawa Nobuyuki;Hattori Norimichi;Harada Hiroshi, International journal of hematology, 118(5):636 - 641, 2023年07月, 査読あり, DOI:10.1007/s12185-023-03636-5
  • Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor., Hamada Kazuyuki;Isobe Junya;Hattori Kouya;Hosonuma Masahiro;Baba Yuta;Murayama Masakazu;Narikawa Yoichiro;Toyoda Hitoshi;Funayama Eiji;Tajima Kohei;Shida Midori;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kiuchi Yuji;Kobayashi Shinichi;Kuramasu Atsuo;Horiike Atsushi;Kim Yun-Gi;Tsunoda Takuya;Yoshimura Kiyoshi, Frontiers in immunology, 14:1164724, 2023年05月, 原著, 査読あり, DOI:10.3389/fimmu.2023.1164724
  • Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor., Kazuyuki Hamada, Junya Isobe, Kouya Hattori, Masahiro Hosonuma, Yuta Baba, Masakazu Murayama, Yoichiro Narikawa, Hitoshi Toyoda, Eiji Funayama, Kohei Tajima, Midori Shida, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Yuji Kiuchi, Shinichi Kobayashi, Atsuo Kuramasu, Atsushi Horiike, Yun-Gi Kim, Takuya Tsunoda and Kiyoshi Yoshimura, Front Immunol., 14:1164724, 2023年05月, 原著, 査読あり, DOI:10.3389/fimmu.2023.1164724
  • Successful Treatment of an Aggressive Adult T-cell Leukemia/Lymphoma with Strong CD30 Expression Using Brentuximab Vedotin as Combination and Maintenance Therapy., Baba Yuta;Sakai Hirotaka;Kabasawa Nobuyuki;Harada Hiroshi, Internal medicine (Tokyo, Japan), 62(4):613- - 616, 2022年07月, 査読あり, DOI:10.2169/internalmedicine.9812-22
  • Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination., Baba Yuta;Sakai Hirotaka;Kabasawa Nobuyuki;Harada Hiroshi, Internal medicine (Tokyo, Japan), 61(12):1891 - 1895, 2022年04月, 査読あり, DOI:10.2169/internalmedicine.9199-21
  • Extranodal NK/T-cell lymphoma in a unilateral adrenal tumor., Baba Yuta;Sakai Hirotaka;Abe Maasa;Kabasawa Nobuyuki, Japanese journal of clinical oncology, 52(12):1450 - 1451, 2022年, 査読あり, DOI:10.1093/jjco/hyac134
  • Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes., Baba Yuta;Saito Bungo;Shimada Shotaro;Sasaki Yohei;Fujiwara Shun;Arai Nana;Kawaguchi Yukiko;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Hattori Norimichi;Harada Hiroshi;Nakamaki Tsuyoshi, International journal of hematology, 114(4), 2021年07月, 原著, 査読あり
  • Analysis of the MYD88 L265P mutation in IgM monoclonal gammopathy by semi-nested polymerase chain reaction-based restriction fragment length polymorphism method, FUJIWARA Shun;BABA Yuta;SASAKI Yohei;SHIMADA Shotaro;MURAI So;ARAI Nana;KAWAGUCHI Yukiko;HATTORI Norimichi;SHIOZAWA Eisuke;YAMOCHI Toshiko;FUKUCHI Kunihiko;NAKAMAKI Tsuyoshi, Showa Univ J Med Sci, 33(2):47 - 54, 2021年06月, 原著, 査読あり, DOI:10.15369/sujms.33.47
  • A Cluster of Respiratory Syncytial Virus Infections in a Hospital Ward for Adult Immunocompromised Patients, NAGATOMO Yasuhiro ;TAKUMA Takahiro;TOKIMATSU Issei;NIKI Yoshihito;FUJIWARA Shun;NAKATA Ayaka;SASAKI Youhei;SHIMADA Shotaro;WATANUKI Megumi;ABE Maasa;MURAI So;BABA Yuta;KAWAGUCHI Yukiko;ARAI Nana;KABASAWA Nobuyuki;MATSUI Tomoharu;TSUKAMOTO Hiroyuki;UTO Yui;HATTORI Norimichi;SAITO Bungo;YANAGISAWA Kouji;NAKAMAKI Tsuyoshi, Showa Univ J Med Sci, 32(4):257 - 264, 2021年01月, 査読あり
  • Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders., Kabasawa Nobuyuki;Shiozawa Eisuke;Murai So;Homma Mayumi;Uesugi Yuka;Matsui Tomoharu;Nakata Ayaka;Shimada Shotaro;Sasaki Yohei;Baba Yuta;Watanuki Megumi;Arai Nana;Fujiwara Shun;Kawaguchi Yukiko;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Hattori Norimichi;Sakai Hirotaka;Harada Hiroshi;Nakamaki Tsuyoshi;Takimoto Masafumi;Yamochi-Onizuka Toshiko, Journal of clinical and experimental hematopathology : JCEH, 61(3), 2021年, 原著, 査読あり
  • Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy., Kawaguchi Yukiko;Saito Bungo;Nakata Ayaka;Matsui Tomoharu;Sasaki Yohei;Shimada Shotaro;Abe Maasa;Watanuki Megumi;Baba Yuta;Murai So;Arai Nana;Fujiwara Shun;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Hattori Norimichi;Harada Hiroshi;Nakamaki Tsuyoshi, International journal of hematology, 112(3), 2020年06月, 原著, 査読あり
  • Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation., Fujiwara Shun;Hattori Norimichi;Matsui Tomoharu;Nakata Ayaka;Sasaki Yohei;Shimada Shotaro;Murai So;Abe Maasa;Baba Yuta;Watanuki Megumi;Kawaguchi Yukiko;Arai Nana;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Harada Hiroshi;Nakamaki Tsuyoshi, Transplantation proceedings, 51(10), 2019年11月, 原著, 査読あり
  • Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults., Hattori Norimichi;Saito Bungo;Matsui Tomoharu;Nakata Ayaka;Sasaki Yohei;Shimada Shotaro;Murai So;Abe Maasa;Baba Yuta;Watanuki Megumi;Fujiwara Shun;Kawaguchi Yukiko;Arai Nana;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Harada Hiroshi;Nakamaki Tsuyoshi, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 26(2), 2019年10月, 原著, 査読あり
  • Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia., Arai Nana;Homma Mayumi;Abe Maasa;Baba Yuta;Murai So;Watanuki Megumi;Kawaguchi Yukiko;Fujiwara Shun;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Ariizumi Hirotsugu;Yanagisawa Kouji;Hattori Norimichi;Saito Bungo;Shiozawa Eisuke;Harada Hiroshi;Yamochi-Onizuka Toshiko;Nakamaki Tsuyoshi;Takimoto Masafumi, International journal of hematology, 109(5), 2019年03月, 原著, 査読あり
  • Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia., Hattori Norimichi;Kawaguchi Yukiko;Sasaki Yohei;Shimada Shotaro;Murai So;Abe Maasa;Baba Yuta;Watanuki Megumi;Fujiwara Shun;Arai Nana;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Yanagisawa Kouji;Saito Bungo;Harada Hiroshi;Nakamaki Tsuyoshi, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 25(5), 2019年01月, 原著, 査読あり
  • 心タンポナーデで発症し経時的に変化する不整脈を伴ったびまん性大細胞型B細胞リンパ腫, 馬場 勇太;齋藤 文護;島田 翔太郎;佐々木 陽平;村井 聡;阿部 真麻;藤原 峻;荒井 奈々;川口 有紀子;蒲澤 宣幸;塚本 裕之;宇藤 唯;柳沢 孝次;服部 憲路;原田 浩史;中牧 剛, 臨床血液, 60(6):577 - 581, 2019年, 査読あり, DOI:10.11406/rinketsu.60.577
  • Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome., HATTORI Norimichi;SAITO Bungo;SASAKI Yohei;SHIMADA Shotaro;MURAI So;ABE Maasa;BABA Yuta;WATANUKI Megumi;FUJIWARA Shun;KAWAGUCHI Yukiko;ARAI Nana;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HARADA Hiroshi;NAKAMAKI Tsuyoshi, Biol Blood Marrow Transplant, 24(9):1841 - 1847, 2018年09月, 原著, 査読あり
  • Ki-67 expression of immunohistochemistry using computerized image analysis is a useful prognostic marker in follicular lymphomas., Kawaguchi Yukiko;Shiozawa Eisuke;Shimada Shotaro;Sasaki Yohei;Abe Maasa;Murai So;Baba Yuta;Arai Nana;Okamoto Naoko;Kabasawa Nobuyuki;Homma Mayumi;Saito Bungo;Yamochi-Onizuka Toshiko;Nakamaki Tsuyoshi;Takimoto Masafumi, International journal of clinical and experimental pathology, 11(7), 2018年07月, 原著, 査読あり
  • Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome., Baba Yuta;Saito Bungo;Shimada Shotaro;Sasaki Yohei;Murai So;Abe Maasa;Fujiwara Shun;Arai Nana;Kawaguchi Yukiko;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Ariizumi Hirotsugu;Yanagisawa Kouji;Hattori Norimichi;Harada Hiroshi;Nakamaki Tsuyoshi, Leukemia research, 67, 2018年02月, 原著, 査読あり
  • Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma., Kawaguchi Yukiko;Nakamaki Tsuyoshi;Abe Maasa;Baba Yuta;Murai So;Watanuki Megumi;Arai Nana;Fujiwara Shun;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Ariizumi Hirotsugu;Yanagisawa Kouji;Hattori Norimichi;Harada Hiroshi;Saito Bungo, Acta haematologica, 139(1), 2018年01月, 原著, 査読あり
  • 多発性骨髄腫に対するVRD療法中に発症した抗利尿ホルモン不適合分泌症候群, 馬場 勇太;原田 浩史;島田 翔太郎;佐々木 陽平;村井 聡;阿部 真麻;藤原 峻;荒井 奈々;川口 有紀子;蒲澤 宣幸;塚本 裕之;宇藤 唯;有泉 裕嗣;柳沢 孝次;服部 憲路;齋藤 文護;中牧 剛, 臨床血液, 59(11):2423 - 2427, 2018年, 査読あり, DOI:10.11406/rinketsu.59.2423
  • Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin's lymphoma patients undergoing repeated cycles of the CHOP regimen., Saito Bungo;Nakashima Hidetoshi;Abe Maasa;Murai So;Baba Yuta;Arai Nana;Kawaguchi Yukiko;Fujiwara Shun;Kabasawa Nobuyuki;Tsukamoto Hiroyuki;Uto Yui;Ariizumi Hirotsugu;Yanagisawa Kouji;Hattori Norimichi;Harada Hiroshi;Nakamaki Tsuyoshi, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 26(1), 2017年08月, 原著, 査読あり
  • 骨髄芽球の増加を伴う高リスク骨髄異形成症候群の患者におけるアザシチジン療法の予後予測因子, 塚本 裕之;斎藤 文護;阿部 真麻;村井 聡;馬場 勇太;綿貫 めぐみ;荒井 奈々;川口 有紀子;蒲澤 宣幸;宇藤 唯;服部 憲路;柳澤 孝次;中牧 剛, 昭和学士会雑誌, 77(2):181 - 187, 2017年, 原著, 査読あり, DOI:10.14930/jshowaunivsoc.77.181
  • NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study., Akatsuki Kokaze; Masao Yoshida; Mamoru Ishikawa; Naomi Matsunaga; Kanae Karita; Tadahiro Ohtsu; Hirotaka Ochiai; Takako Shirasawa; Hinako Nanri; Yuta Baba; Hiromi Hoshino; Yutaka Takashima, Tobacco induced diseases, 12(1):11 - 11, 2014年, 原著, 査読あり

講演・口頭発表等

  • Lenalidomide reduces MDS clone with 17p deletion, 馬場勇太, 服部憲路, 川口有紀子, 村井聡, 阿部真麻, 綿貫めぐみ, 藤原峻, 荒井奈々, 蒲澤宣幸, 塚本裕之, 宇藤唯, 有泉裕嗣, 柳沢孝次, 齋藤文護, 原田浩史, 中牧剛, 第78回日本血液学会学術集会, 2016年10月
  • 総腸骨動脈瘤を合併したベーチェット病の一例, 馬場勇太, 高橋良, 古屋秀和, 石井翔, 磯崎健男, 磯島咲子, 三輪裕介, 笠間毅, 第59回日本リウマチ学会総会・学術集会, 2015年04月

書籍等出版物

  • 実験医学 2024年1月号 Vol.42 No.1, 腸内細菌とがん免疫応答―がん免疫療法の有効性を高める一つの鍵, 馬場勇太　吉村清, 分担執筆, 羊土社, 2023年12月
  • 別冊 領域別症候群シリーズ No.26 血液症候群（第３版）I, 潜性遺伝性家族性赤血球増加症, 馬場勇太　福田哲也, 分担執筆, 日本臨牀社, 2023年09月

共同研究・競争的資金等の研究課題

  • 悪性リンパ腫における腸内細菌を介したT・NK細胞疲弊制御に よる治療感受性の検討, 馬場勇太, 臨床薬理研究振興財団, 研究開始 20260401, 研究終了 20270331
  • 骨髄異形成症候群の疾患活動性を制御する腸内細菌・短鎖脂肪酸の解析, 馬場勇太, 日本学術振興会, 科学研究費助成事業, 若手研究, 研究開始 20260401, 研究終了 20290331
  • びまん性大細胞型B細胞リンパ腫の治療感受性を決定する腸内細菌・短鎖脂肪酸の解析, 馬場勇太, 日本学術振興会, 科学研究費助成事業, 若手研究, 研究開始 2024/04/01, 研究終了 2027/03/31
  • 悪性リンパ腫における短鎖脂肪酸のT・NK細胞疲弊改善を介した抗腫瘍効果の増強, 馬場勇太, 日本白血病研究基金, 研究開始 20230901, 研究終了 20240831

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.